<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38106125</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2023</Year><Month>Dec</Month><Day>05</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 Infection is Associated with an Increase in New Diagnoses of Schizophrenia Spectrum and Psychotic Disorder: A Study Using the US National COVID Cohort Collaborative (N3C).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2023.12.05.23299473</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2023.12.05.23299473</ELocationID><Abstract><AbstractText>Amid the ongoing global repercussions of SARS-CoV-2, it's crucial to comprehend its potential long-term psychiatric effects. Several recent studies have suggested a link between COVID-19 and subsequent mental health disorders. Our investigation joins this exploration, concentrating on Schizophrenia Spectrum and Psychotic Disorders (SSPD). Different from other studies, we took acute respiratory distress syndrome (ARDS) and COVID-19 lab negative cohorts as control groups to accurately gauge the impact of COVID-19 on SSPD. Data from 19,344,698 patients, sourced from the N3C Data Enclave platform, were methodically filtered to create propensity matched cohorts: ARDS (n = 222,337), COVID-positive (n = 219,264), and COVID-negative (n = 213,183). We systematically analyzed the hazard rate of new-onset SSPD across three distinct time intervals: 0-21 days, 22-90 days, and beyond 90 days post-infection. COVID-19 positive patients consistently exhibited a heightened hazard ratio (HR) across all intervals [0-21 days (HR: 4.6; CI: 3.7-5.7), 22-90 days (HR: 2.9; CI: 2.3 -3.8), beyond 90 days (HR: 1.7; CI: 1.5-1.)]. These are notably higher than both ARDS and COVID-19 lab-negative patients. Validations using various tests, including the Cochran Mantel Haenszel Test, Wald Test, and Log-rank Test confirmed these associations. Intriguingly, our data indicated that younger individuals face a heightened risk of SSPD after contracting COVID-19, a trend not observed in the ARDS and COVID-negative groups. These results, aligned with the known neurotropism of SARS-CoV-2 and earlier studies, accentuate the need for vigilant psychiatric assessment and support in the era of Long-COVID, especially among younger populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rahman</LastName><ForeName>Asif</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Industrial &amp; Management Systems Engineering, West Virginia University, Morgantown, WV, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, West Virginia University, Morgantown, WV, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Wanhong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>School of Medicine, West Virginia University, Morgantown, WV, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckrich</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-0977-3275</Identifier><AffiliationInfo><Affiliation>Nemours Children's Health, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Imtiaz</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Industrial &amp; Management Systems Engineering, West Virginia University, Morgantown, WV, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 GM104938</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002649</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002548</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001433</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001422</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001860</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001427</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104942</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001420</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001439</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003096</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002537</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001857</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001412</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM133807</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001872</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001878</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002529</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002494</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002736</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115516</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002369</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002541</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115371</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002001</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002538</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115458</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001442</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002535</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001866</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003167</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001409</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001449</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001453</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002489</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104940</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003107</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>INV-018455</GrantID><Acronym>GATES</Acronym><Agency>Bill &amp; Melinda Gates Foundation</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003015</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002733</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 TR002306</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002003</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001876</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001436</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002378</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002384</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002553</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002389</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001414</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104941</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002014</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002550</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002319</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001855</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001425</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002373</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002240</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 TR004399</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002556</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003017</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001998</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001881</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002645</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002366</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115428</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002345</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002377</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115677</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002544</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003098</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001430</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003142</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>PLoS One. 2024 May 30;19(5):e0295891. doi: 10.1371/journal.pone.0295891</RefSource><PMID Version="1">38814888</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>18</Day><Hour>4</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38106125</ArticleId><ArticleId IdType="pmc">PMC10723510</ArticleId><ArticleId IdType="doi">10.1101/2023.12.05.23299473</ArticleId><ArticleId IdType="pii">2023.12.05.23299473</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schou T., Joca S., Wegener G. &amp; Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19&#x2013;A systematic review. Brain, Behavior, And Immunity. 97 pp. 328&#x2013;348 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8363196</ArticleId><ArticleId IdType="pubmed">34339806</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X. &amp; Others 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet. 397, 220&#x2013;232 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J., Husain M., Luciano S. &amp; Harrison P. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry. 8, 416&#x2013;427 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Egbert A., Cankurtaran S. &amp; Karpiak S. Brain abnormalities in COVID-19 acute/subacute phase: a rapid systematic review. Brain, Behavior, And Immunity. 89 pp. 543&#x2013;554 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7366124</ArticleId><ArticleId IdType="pubmed">32682993</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J., Griffanti L., Duff E. &amp; Others SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 604, 697&#x2013;707 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Veldhuis A. &amp; Malhotra T. Neuropsychiatric and cognitive sequelae of COVID-19. Frontiers In Psychology. 12 pp. 577529 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7960660</ArticleId><ArticleId IdType="pubmed">33737894</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C., Collange O., Boulay C., Fafi-Kremer S., Ohana M. &amp; Others Neurologic features in severe SARS-CoV-2 infection. New England Journal Of Medicine. 382, 2268&#x2013;2270 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong X., Zheng K., Tang M., Kong F., Zhou J., Diao L., Wu S., Jiao P., Su T. &amp; Dong Y. Prevalence and factors associated with depression and anxiety of hospitalized patients with COVID-19. MedRxiv. pp. 2020&#x2013;03 (2020).</Citation></Reference><Reference><Citation>Pavlov VA, Tracey KJ. Neural circuitry and immunity. Immunologic research. 2015. Dec;63:38&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4743890</ArticleId><ArticleId IdType="pubmed">26512000</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimian R, Wakid M, O&#x2019;Leary LA, Mechawar N. The emerging tale of microglia in psychiatric disorders. Neuroscience &amp; Biobehavioral Reviews. 2021. Dec 1;131:1&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">34536460</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietz AG, Goldman SA, Nedergaard M. Glial cells in schizophrenia: a unified hypothesis. The Lancet Psychiatry. 2020. Mar 1;7(3):272&#x2013;81..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267935</ArticleId><ArticleId IdType="pubmed">31704113</ArticleId></ArticleIdList></Reference><Reference><Citation>Tr&#xe9;panier MO, Hopperton KE, Mizrahi R, Mechawar N, Bazinet RP. Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. Molecular psychiatry. 2016. Aug;21(8):1009&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4960446</ArticleId><ArticleId IdType="pubmed">27271499</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondelli V, Vernon AC, Turkheimer F, Dazzan P, Pariante CM. Brain microglia in psychiatric disorders. The Lancet Psychiatry. 2017. Jul 1;4(7):563&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">28454915</ArticleId></ArticleIdList></Reference><Reference><Citation>Kealy J, Murray C, Griffin EW, Lopez-Rodriguez AB, Healy D, Tortorelli LS, Lowry JP, Watne LO, Cunningham C. Acute inflammation alters brain energy metabolism in mice and humans: role in suppressed spontaneous activity, impaired cognition, and delirium. Journal of Neuroscience. 2020. Jul 15;40(29):5681&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7363463</ArticleId><ArticleId IdType="pubmed">32513828</ArticleId></ArticleIdList></Reference><Reference><Citation>Girard TD, Ware LB, Bernard GR, Pandharipande PP, Thompson JL, Shintani AK, Jackson JC, Dittus RS, Ely EW. Associations of markers of inflammation and coagulation with delirium during critical illness. Intensive care medicine. 2012. Dec;38:1965&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3606929</ArticleId><ArticleId IdType="pubmed">22903241</ArticleId></ArticleIdList></Reference><Reference><Citation>McNeil JB, Hughes CG, Girard T, Ware LB, Ely EW, Chandrasekhar R, Han JH. Plasma biomarkers of inflammation, coagulation, and brain injury as predictors of delirium duration in older hospitalized patients. PLoS One. 2019. Dec 19;14(12):e0226412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6922408</ArticleId><ArticleId IdType="pubmed">31856187</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano-Vicario L, Garc&#xed;a-Hermoso A, Cedeno-Veloz BA, Fern&#xe1;ndez-Irigoyen J, Santamar&#xed;a E, Romero-Ortuno R, Zambom-Ferraresi F, S&#xe1;ez de Asteasu ML, Mu&#xf1;oz-V&#xe1;zquez &#xc1;J, Izquierdo M, Mart&#xed;nez-Velilla N. Biomarkers of delirium risk in older adults: a systematic review and meta-analysis. Frontiers in Aging Neuroscience. 2023. May 12;15:1174644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10213257</ArticleId><ArticleId IdType="pubmed">37251808</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong TG, Inouye SK. The inter-relationship between delirium and dementia: the importance of delirium prevention. Nature Reviews Neurology. 2022. Oct;18(10):579&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9415264</ArticleId><ArticleId IdType="pubmed">36028563</ArticleId></ArticleIdList></Reference><Reference><Citation>Culley DJ, Flaherty D, Fahey MC, Rudolph JL, Javedan H, Huang CC, Wright J, Bader AM, Hyman BT, Blacker D, Crosby G. Poor performance on a preoperative cognitive screening test predicts postoperative complications in older orthopedic surgical patients. Anesthesiology. 2017. Nov 1;127(5):765&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5657553</ArticleId><ArticleId IdType="pubmed">28891828</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis DH, Skelly DT, Murray C, Hennessy E, Bowen J, Norton S, Brayne C, Rahkonen T, Sulkava R, Sanderson DJ, Rawlins JN. Worsening cognitive impairment and neurodegenerative pathology progressively increase risk for delirium. The American journal of geriatric psychiatry. 2015. Apr 1;23(4):403&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4278840</ArticleId><ArticleId IdType="pubmed">25239680</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander SA, Conley YP, Girard TD, McVerry BJ, Ren D. Temporal Variability in Inflammatory Gene Methylation and Delirium in Critically Ill Patients. American Journal of Critical Care. 2022. Sep 1;31(5):367&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">36045041</ArticleId></ArticleIdList></Reference><Reference><Citation>Widmann CN, Heneka MT. Long-term cerebral consequences of sepsis. The Lancet Neurology. 2014. Jun 1;13(6):630&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24849863</ArticleId></ArticleIdList></Reference><Reference><Citation>Rengel KF, Hayhurst CJ, Pandharipande PP, Hughes CG. Long-term cognitive and functional impairments after critical illness. Anesthesia&amp; Analgesia. 2019. Apr 1;128(4):772&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">30883422</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence Jablensky A. and incidence of schizophrenia spectrum disorders: implications for prevention. Australian &amp; New Zealand Journal of Psychiatry. 2000. Feb;34(1 suppl):A26&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">11129313</ArticleId></ArticleIdList></Reference><Reference><Citation>Yirmiya R, Rimmerman N, Reshef R. Depression as a microglial disease. Trends in neurosciences. 2015. Oct 1;38(10):637&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">26442697</ArticleId></ArticleIdList></Reference><Reference><Citation>McAllen RM, McKinley MJ, Martelli D. Reflex regulation of systemic inflammation by the autonomic nervous system. Autonomic Neuroscience. 2022. Jan 1;237:102926.</Citation><ArticleIdList><ArticleId IdType="pubmed">34906897</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerejeira J, Nogueira V, L&#xfa;&#x131;s P, Vaz-Serra A, Mukaetova-Ladinska EB. The cholinergic system and inflammation: common pathways in delirium pathophysiology. Journal of the American Geriatrics Society. 2012. Apr;60(4):669&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">22316182</ArticleId></ArticleIdList></Reference><Reference><Citation>Salter MW, Stevens B. Microglia emerge as central players in brain disease. Nature medicine. 2017. Sep 1;23(9):1018&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">28886007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kealy J, Murray C, Griffin EW, Lopez-Rodriguez AB, Healy D, Tortorelli LS, Lowry JP, Watne LO, Cunningham C. Acute inflammation alters brain energy metabolism in mice and humans: role in suppressed spontaneous activity, impaired cognition, and delirium. Journal of Neuroscience. 2020. Jul 15;40(29):5681&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7363463</ArticleId><ArticleId IdType="pubmed">32513828</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith RJ, Rabinstein AA, Cartin-Ceba R, Singh VP, Lachner C, Khatua B, Trivedi S, Gajic O. Chemokines in ICU Delirium: An Exploratory Study. Critical Care Explorations. 2022. Jul;4(7).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9259165</ArticleId><ArticleId IdType="pubmed">35815182</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreuder L, Eggen BJ, Biber K, Schoemaker RG, Laman JD, de Rooij SE. Pathophysiological and behavioral effects of systemic inflammation in aged and diseased rodents with relevance to delirium: a systematic review. Brain, Behavior, and Immunity. 2017. May 1;62:362&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">28088641</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaak C, Vorderw&#xfc;lbecke G, Spies C, Piper SK, Hadzidiakos D, Borchers F, Brockhaus WR, Radtke FM, Lachmann G. C-reactive protein for risk prediction of post-operative delirium and post-operative neurocognitive disorder. Acta Anaesthesiologica Scandinavica. 2019. Nov;63(10):1282&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">31283835</ArticleId></ArticleIdList></Reference><Reference><Citation>Brummel NE, Hughes CG, Thompson JL, Jackson JC, Pandharipande P, McNeil JB, Raman R, Orun OM, Ware LB, Bernard GR, Ely EW. Inflammation and coagulation during critical illness and long-term cognitive impairment and disability. American journal of respiratory and critical care medicine. 2021. Mar 15;203(6):699&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7958515</ArticleId><ArticleId IdType="pubmed">33030981</ArticleId></ArticleIdList></Reference><Reference><Citation>McNeil JB, Hughes CG, Girard T, Ware LB, Ely EW, Chandrasekhar R, Han JH. Plasma biomarkers of inflammation, coagulation, and brain injury as predictors of delirium duration in older hospitalized patients. PLoS One. 2019. Dec 19;14(12):e0226412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6922408</ArticleId><ArticleId IdType="pubmed">31856187</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanazz K, Nalloor R, Lucas R, Vazdarjanova A. Neuroinflammation is a susceptibility factor in developing a PTSD-like phenotype. Frontiers in Behavioral Neuroscience. 2023. Mar 29;17:1112837.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10090279</ArticleId><ArticleId IdType="pubmed">37064304</ArticleId></ArticleIdList></Reference><Reference><Citation>Speer K, Upton D, Semple S, McKune A. Systemic low-grade inflammation in post-traumatic stress disorder: a systematic review. Journal of inflammation research. 2018. Mar 22:111&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5868606</ArticleId><ArticleId IdType="pubmed">29606885</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo C, Zhuang Z, Yang P, Zhang H, Li X, Huang T, Ahluwalia TS. Dissecting the causal association between inflammation and post-traumatic stress disorder: A bidirectional Mendelian randomization study. Journal of Affective Disorders. 2023. Jul 15;333:436&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">37086801</ArticleId></ArticleIdList></Reference><Reference><Citation>Herridge MS, Azoulay E. Outcomes after critical illness. New England Journal of&#xb4; Medicine. 2023. Mar 9;388(10):913&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">36884324</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung JY, Singh M, Yinda CK, Winkler CW, Sun J, Dickey JM, Ylaya K, Ko SH. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022. Dec 22;612(7941):758&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Albornoz EA, Amarilla AA, Modhiran N, Parker S, Li XX, Wijesundara DK, Aguado J, Zamora AP, McMillan CL, Liang B, Peng NY. SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein. Molecular psychiatry. 2022. Nov 1:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10615762</ArticleId><ArticleId IdType="pubmed">36316366</ArticleId></ArticleIdList></Reference><Reference><Citation>Steardo L Jr, Steardo L, Verkhratsky A. Psychiatric face of COVID-19. Translational psychiatry. 2020. Jul 30;10(1):261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391235</ArticleId><ArticleId IdType="pubmed">32732883</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with covid-19: cohort study. bmj. 2022. Feb 16;376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8847881</ArticleId><ArticleId IdType="pubmed">35172971</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman B, Casiraghi E, Blau H, Chan L, Haendel MA, Laraway B, Callahan TJ, Deer RR, Wilkins KJ, Reese J, Robinson PN. Risk of new-onset psychiatric sequelae of COVID-19 in the early and late post-acute phase. World Psychiatry. 2022. Jun;21(2):319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9077621</ArticleId><ArticleId IdType="pubmed">35524622</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 69, 239&#x2013;241 (1982).</Citation></Reference><Reference><Citation>Agresti A. Categorical data analysis. John Wiley &amp; Sons; 2012. Dec 3.</Citation></Reference><Reference><Citation>Li B, Babu GJ. A graduate course on statistical inference. Springer New York; 2019. Aug 2.</Citation></Reference><Reference><Citation>Hammond F, Malec J, Nick T, Buschbacher R, editors. Handbook for clinical research: design, statistics, and implementation. Demos Medical Publishing; 2014. Aug 26.</Citation></Reference><Reference><Citation>Ngasa SN, Tchouda LA, Abanda C, Ngasa NC, Sanji EW, Dingana TN, Babila CS. Prevalence and factors associated with anxiety and depression amongst hospitalised COVID-19 patients in Laquintinie Hospital Douala, Cameroon. PLoS One. 2021. Dec 2;16(12):e0260819.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8638855</ArticleId><ArticleId IdType="pubmed">34855877</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R, Ciceri F, Rovere-Querini P, Benedetti F, COVID-19 BioB Outpatient Clinic Study group. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain, behavior, and immunity. 2021. May 1;94:138&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>N3C computable phenotype: COVID-19 Phenotype Documentation, Version 4.0. https://github.com/National-COVID-Cohort-Collaborative/PhenotypeDataAcquisition/wiki/Latest-Phenotype. Updated March 11, 2022.9.</Citation></Reference><Reference><Citation>OHDSI Standardized Data. https://www.ohdsi.org/data-standardization/. Accessed November 10, 2022.</Citation></Reference><Reference><Citation>Kempf L., Hussain N. &amp; Potash J. Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: trouble at the borders. International Review Of Psychiatry. 17, 9&#x2013;19 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16194767</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewine R. &amp; Hart M. Schizophrenia spectrum and other psychotic disorders. Handbook Of Clinical Neurology. 175 pp. 315&#x2013;333 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33008535</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>